Home » Topics » Gastrointestinal, BioWorld Science

Gastrointestinal, BioWorld Science
RSS

rhIL-11 tested in active Crohn's disease

Sep. 16, 1999

XTL and Lilly to collaborate on HCV therapy research

Sep. 14, 1999

Isis and Abbott initiate collaboration for antisense drugs

Sep. 14, 1999

LEX-032, a recombinant serpin with beneficial effects on ischemia/reperfusion-induced pancreatitis

Sep. 13, 1999

New acylquinoline selected for development as antiulcer agent by Korean investigators

Sep. 13, 1999

Oxagen broadens collaboration in IBD research

Sep. 13, 1999

Synsorb Biotech searches for treatments for bacterial toxin-induced diseases

Sep. 13, 1999

New naturally occurring hepatoprotective/immunostimulating compound from Il Yang in phase II

Sep. 10, 1999

Licensing opportunity from NIH: antisense oligonucleotides for treating Crohn's disease

Sep. 9, 1999

Isis reacquires full rights to ISIS-2302 and negotiates with commercialization partners

Sep. 7, 1999

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...